1. BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions;Proietti I.;Cancers.,1823
2. Clinical Development of BRAF plus MEK Inhibitor Combinations;Subbiah V.;Trends Cancer.,2020
3. clinicaltrials.gov.
4. Vemurafenib: the first drug approved for BRAF‐mutant cancer;Bollag G.;Nat. Rev. Drug Discov.,2012
5. The ras pathway and cancer: regulation, challenges and the therapeutic progress;Trott M.;Technology Networks. May,2021